侦察鱼群网
基于1个网页-相关网页
The stage is now set for Tave to launch a generic, although it must will obtain FDA approval and survive a planned appeal by Bristol-Myers.
FORBES: Not So Obvious: A Bristol-Myers Patent Defeat May Change Wall Street Views
应用推荐
模块上移
模块下移
不移动